ePrivacy and GPDR Cookie Consent by TermsFeed Generator

About the Webinar:

3D genomics is a powerful NGS approach that provides unparalleled access to the sequence, structure, and regulatory landscape of genomes. In this joint webinar with Agilent Technologies, Anthony Schmitt, SVP of Science at Arima Genomics, shares how 3D genomics allows researchers to study noncoding regions of the genome, explore structural variants driving disease, and identify new therapeutic targets.

Key Takeaways

  • Hear about exciting new developments in 3D genome technologies and workflows
  • Learn how to use targeted 3D genome methods, including capture Hi-C, to characterize regulatory interactions, noncoding elements, and structural variants
  • Find answers to common questions during the Q&A session at the end

Meet the Speakers:

Anthony Schmitt, PhD

SVP, Science at Arima Genomics

Anthony Schmitt is the senior vice president of science at Arima Genomics. He has led the development of the core Arima-HiC chemistry and technology platform since Arima’s inception, contributed to core inventions and technology development grants, and continues to lead their R&D programs for targeted chromosome conformation capture techniques such as HiChIP and capture HiC.

Anthony received a doctorate in biomedical sciences from UC San Diego in the laboratory of Bing Ren and a bachelor’s degree in biology from the University of Massachusetts Amherst. During his doctoral training, Schmitt played roles in developing and applying Hi-C technologies, with notable contributions to our understanding of gene regulation in nearly 30 human tissues using Hi-C and promoter capture HiC.

Kathryn Woodfine

Global Product Manager, Agilent

Kathryn Woodfine is the global product manager for the Agilent SureSelect Custom probe portfolio. Woodfine has over two decades of experience in the field of genomics. She has a doctorate in molecular genetics from the University of Cambridge where she worked at the Wellcome Trust Sanger Institute and contributed to the Human Genome Project.

After postdoctoral positions at King’s College London and Cancer Research UK, Woodfine began her commercial career within Roche before moving to Agilent. She has spent five years supporting customers in the field before transitioning to the role of product manager because of her passion for SureSelect targeted sequencing.